ELTP & Teva: The New Jersey Drug Acquisition Puzzle With a Surprise Price Tag
Andrew Foster | New Jersey Bureau
New Jersey. 8:15 PM. A generic drug acquisition proposal reaches the negotiating table. Manufacturing rights, product portfolios, and distribution agreements become the bargaining chips.
A final valuation has been proposed. The answer remains sealed. Check back for the next dispatch.
Continue Your Research
Browse the Stock Ratings Directory
Explore Buyout Watch
Visit the Trading Academy
Browse Biotech Catalyst Watch
Browse OTC Buzz Tracker